Literature DB >> 18054573

How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers.

Ulrich Thalheimer1, Jaime Bosch, Andrew K Burroughs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18054573     DOI： 10.1053/j.gastro.2007.10.028

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  16 in total

1.  Primary prophylaxis of variceal bleeding.

Authors:  Maria Yago Baenas; Ulrich Thalheimer; Giacomo Germani; Andrew K Burroughs
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-08

2.  Pharmacological effects are model specific in animal models of portal hypertension.

Authors:  Flemming Bendtsen; Søren Møller
Journal:  Hepatol Int       Date:  2008-09-03       Impact factor: 6.047

3.  Use of non-selective beta blockers in cirrhosis: the evidence we need before closing (or not) the window.

Authors:  Vincenzo La Mura; Giulia Tosetti; Massimo Primignani; Francesco Salerno
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 4.  Management of varices in patients with cirrhosis.

Authors:  Julia O'Brien; Christos Triantos; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-02       Impact factor: 46.802

Review 5.  Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension.

Authors:  Alberto Ferrarese; Alberto Zanetto; Giacomo Germani; Patrizia Burra; Marco Senzolo
Journal:  World J Hepatol       Date:  2016-08-28

Review 6.  Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement.

Authors:  Vincenzo La Mura; Antonio Nicolini; Giulia Tosetti; Massimo Primignani
Journal:  World J Hepatol       Date:  2015-04-08

Review 7.  Variceal bleeding : pharmacological treatment and prophylactic strategies.

Authors:  Cándid Villanueva; Joaquim Balanzó
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 8.  Prevention of portal hypertension: from variceal development to clinical decompensation.

Authors:  Julio D Vorobioff; Roberto J Groszmann
Journal:  Hepatology       Date:  2014-09-26       Impact factor: 17.425

9.  Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

Authors:  Tae Wan Kim; Hong Joo Kim; Chang Uk Chon; Hyun Sun Won; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Clin Mol Hepatol       Date:  2012-06-26

10.  Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib.

Authors:  Romain Coriat; Hervé Gouya; Olivier Mir; Stanislas Ropert; Olivier Vignaux; Stanislas Chaussade; Philippe Sogni; Stanislas Pol; Benoit Blanchet; Paul Legmann; François Goldwasser
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.